The U.S. Food and Drug Administration (FDA) is alerting certain prostate cancer patients in South Florida to the possibility that they may have been given inadequate levels of the anti-cancer drug Lupron. This alert applies only to prostate cancer patients who have been treated at Urology P.A. - operated by Dr. Victor Souaid at 2100 East Sample Road, Pompano Beach, Florida.

FDA is issuing this warning because of the potentially significant health implications for prostate cancer patients who may not have received sufficient amounts of Lupron.

FDA strongly advises all patients treated for prostate cancer at Urology P.A. in Pompano Beach, Florida to contact their primary care physician immediately for evaluation and appropriate medical referral.

The reports involving this Florida doctor come only months after a Kansas City pharmacist was accussed of diluting cancer drugs. Several patients in the Kansas City incident have died because of the dilution. Lawsuits have been filed in the Kansas City case and lawyers expect similar suits will be filed against Dr. Souaid.